参考文献/References:
[1]Carvalho IM,Marques CS,Oliveira RS,et al.Sustained drug release by contact lenses for glaucoma treatment-a review[J].J Control Release,2015(202):76-82. [2]Tsai CH,Wang PY,Lin IC,et al.Ocular Drug Delivery:Role of Degradable Polymeric Nanocarriers for Ophthalmic Application[J].Int J Mol Sci,2018,19(9):2830. [3]Rodriguez VJ,Navarro MG,Rodriguez VL,et al.Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives[J].International Journal of Pharmaceutics,2016,511(1):359-366. [4]Herrero-Vanrell R,Bravo-Osuna I,Andrés-Guerrero V,et al.The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies[J].Prog Retin Eye Res,2014(42):27-43. [5]Stukenkemper T,Dose A,Caballo GM,et al.Block Copolypeptide Nanoparticles for the Delivery of Ocular Therapeutics[J].Macromolecular Bioence,2015,15(1):138-145. [6]Haller JA,Bandello F,Belfort R,et al.Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results[J].Ophthalmology,2011(118):2453-2460. [7]Katharina E,Leopold S,Sandra RD,et al.Effects of Intravitreal Dexamethasone Implants on Retinal Oxygen Saturation,Vessel Diameter,and Retrobulbar Blood Flow Velocity in ME Secondary to RVO[J].Investigative Ophthalmology&Visual Science,2017,58(12):5022. [8]Chengxin Z,Marie CR,Vassiliki K,et al.Sustained Subconjunctival Delivery of Infliximab Protects the Cornea and Retina Following Alkali Burn to the Eye[J].Invest Ophthalmol Vis,2017,58(1):96-105. [9]Xu HL,Tong MQ,Wang LF,et al.Thiolated γ-polyglutamic acid as a bioadhesive hydrogel-forming material:evaluation of gelation,bioadhesive properties and sustained release of KGF in the repair of injured corneas[J].Biomater Sci,2019(7):2582-2599. [10]Ferreira AER,Castro BFM,Vieira LC,et al.Antiangiogenic activity of a bevacizumab-loaded polyurethane device in animal neovascularization models[J].Journal Franais Dophtalmologie,2017,40(3):202-208. [11]Wang CH,Hwang YS,Chiang PR,et al.Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel[J].Biomacromolecules,2012(13):40-48. [12]Xu X,Yu J,Shi H,et al.Prevention of corneal neovascularization by subconjunctival injection of avastin○R loaded thermosensitive hydrogels in rabbit model[J].Int J Pharm,2018,552(1-2):164-170. [13]Wang B,Tang Y,Oh Y,et al.Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization[J].Nanomedicine:Nanotechnology,Biology and Medicine,2019(17):119-123. [14]Rao R,Honavar SG.Retinoblastoma[J].Indian Journal of Pediatrics,2017(84):937-944. [15]Suzuki S,Aihara Y,Fujiwara M,et al.Intravitreal injection of melphalan for intraocular retinoblastoma[J].Jpn J Ophthalmol,2015,59(3):164-172. [16]宋尹婷.增生性玻璃体视网膜病变玻璃体内微粒含量变化及其意义[D].天津医科大学,2020. [17]Jastrzembski BG,Shah AS.Microparticle Drug Delivery in Ophthalmology[J].Int Ophthalmol Clin,2017,57(4):129-136. [18]Laurie NA,Gray JK,Zhang J,et al.Topotecan combination chemotherapy in two new rodent models of retinoblastoma[J].Clinical Cancer Research,2005,11(20):7569-7578. [19]Taich P,Moretton MA,Del S,et al.Sustained-release hydrogels of topotecan for retinoblastoma[J].Colloids&Surfaces B Biointerfaces,2016(146):624-631. [20]Sleath B,Blalock S,Covert D,et al.The relationship between glaucoma medication adherence,eye drop technique, and visual field defect severity[J].Ophthalmology,2011,118(12):2398-2402. [21]Chen HY,Lin CL,Tsai YY,et al.Association between Glaucoma Medication Usage and Dry Eye in Taiwan[J].Optometry and Vision Ence,2015,92(9):227-232. [22]Cetinel S,Montemagno C.Nanotechnology Applications for Glaucoma[J].Asia Pac J Ophthalmol,2016,5(1):70-78. [23]Yao W,Sun K,Mu H,et al.Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system[J].Drug Development&Industrial Pharmacy,2010,36(9):1027. [24]Franca JR,Foureaux G,Fuscaldi LL,et al.Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation[J].PLoS One,2014,9(4):e95461. [25]Jung HJ,Chauhan A.Extended Release of Timolol from Nanoparticle-Loaded Fornix Insert for Glaucoma Therapy[J].Journal of Ocular Pharmacology&Therapeutics the Official Journal of the Association for Ocular Pharmacology&Therapeutics,2013,29(2):229-35. [26]Ciolino JB,Stefanescu CF,Ross AE,et al.Invivo performance of a drug-eluting contact lens to treat glaucoma for a month[J].Biomaterials,2014,35(1):432-439. [27]Erdem B,Imamoglu S,Ercalik NY.Needling with 5-fluorouracil for encapsulated blebs after Ahmed glaucoma valve implantation[J].Cutan Ocul Toxicol,2019,38(4):395-400. [28]Liu W,Wang J,Zhang M,et al.Comparison of Subconjunctival Mitomycin C and 5-Fluorouracil Injection for Needle Revision of Early Failed Trabeculectomy Blebs[J].J Ophthalmol,2016(2016):3762674. [29]Cui QN,Hsia YC,Lin SC,et al.Effect of mitomycin c and 5-flurouracil adjuvant therapy on the outcomes of Ahmed glaucoma valve implantation[J].Clin Exp Ophthalmol,2017,45(2):128-134. [30]Bi XZ,Pan WH,Yu XP,et al.Application of 5-Fluorouracil-Polycaprolactone Sustained-Release Film in Ahmed Glaucoma Valve Implantation Inhibits Postoperative Bleb Scarring in Rabbit Eyes[J].PLoS One,2015,10(11):e0141467.
相似文献/References:
[1]司 昕,高 磊,高荣玉,等.视网膜静脉阻塞后视网膜缺血的研究现状[J].医学信息,2021,34(15):25.[doi:10.3969/j.issn.1006-1959.2021.15.007]
SI Xin,GAO Lei,GAO Rong-yu,et al.Current Research Status of Retinal Ischemia After Retinal Vein Occlusion[J].Medical Information,2021,34(02):25.[doi:10.3969/j.issn.1006-1959.2021.15.007]
[2]陆耀楠,庞燕华.视网膜静脉阻塞的治疗现状和进展[J].医学信息,2023,36(14):178.[doi:10.3969/j.issn.1006-1959.2023.14.039]
LU Yao-nan,PANG Yan-hua.Current Status and Progress in the Treatment of Retinal Vein Occlusion[J].Medical Information,2023,36(02):178.[doi:10.3969/j.issn.1006-1959.2023.14.039]
[3]吴 兵,杨学龙,孙 峰.抗VEGF药物治疗视网膜静脉阻塞的效果[J].医学信息,2023,36(23):73.[doi:10.3969/j.issn.1006-1959.2023.23.018]
WU Bing,YANG Xue-long,SUN Feng.Effect of Anti-VEGF Drugs in the Treatment of Retinal Vein Occlusion[J].Medical Information,2023,36(02):73.[doi:10.3969/j.issn.1006-1959.2023.23.018]